● miR-133a can indirectly regulate cellular calcification through RUNX2 gene expression. The results of this study provide insight into miR-133a as a molecular target for the diagnosis of vascular calcification in end-stage renal disease. Here, RUNX2 is linked to stage 5 chronic kidney disease.